ACI-Boston Program Registration
This program has already taken place, to find information on upcoming programs, please check here.Program Agenda
September 27, 2018 ProgramCredit information to be announced. Click here for more detailed CME, CNE and CPE information and program objectives.
Presentations include time for Audience Response System (ARS)-assisted audience interaction as well as general question and answer time.
3:30 – 4:30 p.m.
Check-in, Onsite Registration and Networking
Session I: Introduction to Cancer Immunotherapy
4:30 – 4:35 p.m.
Welcome, Introduction, SITC Resources
4:35 – 5:05 p.m.
Basic Principles of Cancer ImmunotherapyPatrick A. Ott, MD, PhD – Dana-Farber Cancer Institute, Harvard Medical School
5:05 – 5:10 p.m.
Session II: Immunotherapy in Practice
Concurrent Session 1
5:10 – 5:50 p.m.
Immunotherapy for the Treatment of Lung CancerDeepa Rangachari, MD – Beth Israel Deaconess Medical Center
Immunotherapy for the Treatment of MelanomaElizabeth Buchbinder, MD – Dana-Farber Cancer Institute
5:50 – 5:55 p.m.
Concurrent Session 2
5:55 – 6:35 p.m.
Immunotherapy for the Treatment of Head and Neck CancersGlenn J. Hanna, MD – Dana-Farber Cancer Institute
Immunotherapy for the Treatment of Genitourinary MalignanciesKathleen Mahoney, MD, PhD – Beth Israel Deaconess Medical Center
6:35 – 7:05 p.m.
Joint Session (all attendees)
7:05 – 7:45 p.m.
Immunotherapy for the Treatment of Hematologic MalignanciesMyrna R. Nahas, MD – Beth Israel Deaconess Medical Center
Session III: Barriers in Practice
7:45 – 8:30 p.m.
Practical Barriers in Cancer Immunotherapy TreatmentUna Hopkins, RN, FNP-BC, DNP – White Plains Hospital, Dickstein Cancer Treatment CenterPanel Alexandra S. Bailey, MD – Dana-Farber Cancer InstituteRebekah A. Hartwell – Beth Israel Deaconess Medical CenterUna Hopkins, RN, FNP-BC, DNP – White Plains Hospital, Dickstein Cancer Treatment CenterVirginia Seery, MSN, RN, ANP-BC – Beth Israel Deaconess Medical Center
Session IV: The Future of Cancer Immunotherapy
8:30 – 8:55 p.m.
What’s Next for Cancer Immunotherapy?Ryan J. Sullivan, MD – Massachusetts General Hospital
8:55 – 9:00 p.m.
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE- and CNE-accredited programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these 4.5 hour programs will facilitate understanding of:
Attendees will also have an opportunity for connecting with regional experts in the immunotherapy field at the live event, through four quarterly webinars, and indefinitely through a dedicated online community forum. These connections will serve as ongoing resources while clinical oncologists and other healthcare providers incorporate immunotherapy into practice.
For more information, including program objectives, click here.
View the SITC Meeting Code of Conduct.This program is presented in collaboration with the American Academy of Emergency Medicine (AAEM) and the Association of Community Cancer Centers (ACCC).
Wyndham Boston Beacon Hill5 Blossom StreetBoston, MA 02114
Participation in this free online pre-program class is strongly recommended as it contains information that will not be covered at the program on March 24.
This interactive class provides foundational knowledge that is necessary for understanding cancer immunotherapy content that will be discussed at the in-person program. Upon completion of the course, participants can earn continuing education credits (CME, CNE and CPE credits are available).
Click here to access this free class.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org